Literature DB >> 31520103

Less is more: catecholamine-sparing strategies in septic shock.

Balasubramanian Venkatesh1,2,3,4,5, Ashish K Khanna6, Jeremy Cohen7,8,9,10.   

Abstract

Entities:  

Year:  2019        PMID： 31520103     DOI： 10.1007/s00134-019-05770-3

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  20 in total

1.  High versus low blood-pressure target in patients with septic shock.

Authors:  Pierre Asfar; Ferhat Meziani; Jean-François Hamel; Fabien Grelon; Bruno Megarbane; Nadia Anguel; Jean-Paul Mira; Pierre-François Dequin; Soizic Gergaud; Nicolas Weiss; François Legay; Yves Le Tulzo; Marie Conrad; René Robert; Frédéric Gonzalez; Christophe Guitton; Fabienne Tamion; Jean-Marie Tonnelier; Pierre Guezennec; Thierry Van Der Linden; Antoine Vieillard-Baron; Eric Mariotte; Gaël Pradel; Olivier Lesieur; Jean-Damien Ricard; Fabien Hervé; Damien du Cheyron; Claude Guerin; Alain Mercat; Jean-Louis Teboul; Peter Radermacher
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

2.  Positive fluid balance as a prognostic factor for mortality and acute kidney injury in severe sepsis and septic shock.

Authors:  Fernando Saes Vilaça de Oliveira; Flavio Geraldo Resende Freitas; Elaine Maria Ferreira; Isac de Castro; Antonio Toneti Bafi; Luciano Cesar Pontes de Azevedo; Flavia Ribeiro Machado
Journal:  J Crit Care       Date:  2014-09-06       Impact factor: 3.425

3.  Mortality after fluid bolus in African children with severe infection.

Authors:  Kathryn Maitland; Sarah Kiguli; Robert O Opoka; Charles Engoru; Peter Olupot-Olupot; Samuel O Akech; Richard Nyeko; George Mtove; Hugh Reyburn; Trudie Lang; Bernadette Brent; Jennifer A Evans; James K Tibenderana; Jane Crawley; Elizabeth C Russell; Michael Levin; Abdel G Babiker; Diana M Gibb
Journal:  N Engl J Med       Date:  2011-05-26       Impact factor: 91.245

4.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Authors:  Anthony C Gordon; Alexina J Mason; Neeraja Thirunavukkarasu; Gavin D Perkins; Maurizio Cecconi; Magda Cepkova; David G Pogson; Hollmann D Aya; Aisha Anjum; Gregory J Frazier; Shalini Santhakumaran; Deborah Ashby; Stephen J Brett
Journal:  JAMA       Date:  2016-08-02       Impact factor: 56.272

5.  Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.

Authors:  Djillali Annane; Alain Renault; Christian Brun-Buisson; Bruno Megarbane; Jean-Pierre Quenot; Shidasp Siami; Alain Cariou; Xavier Forceville; Carole Schwebel; Claude Martin; Jean-François Timsit; Benoît Misset; Mohamed Ali Benali; Gwenhael Colin; Bertrand Souweine; Karim Asehnoune; Emmanuelle Mercier; Loïc Chimot; Claire Charpentier; Bruno François; Thierry Boulain; Franck Petitpas; Jean-Michel Constantin; Gilles Dhonneur; François Baudin; Alain Combes; Julien Bohé; Jean-François Loriferne; Roland Amathieu; Fabrice Cook; Michel Slama; Olivier Leroy; Gilles Capellier; Auguste Dargent; Tarik Hissem; Virginie Maxime; Eric Bellissant
Journal:  N Engl J Med       Date:  2018-03-01       Impact factor: 91.245

6.  A comparison of epinephrine and norepinephrine in critically ill patients.

Authors:  John A Myburgh; Alisa Higgins; Alina Jovanovska; Jeffrey Lipman; Naresh Ramakrishnan; John Santamaria
Journal:  Intensive Care Med       Date:  2008-07-25       Impact factor: 17.440

7.  Adjunctive Glucocorticoid Therapy in Patients with Septic Shock.

Authors:  Balasubramanian Venkatesh; Simon Finfer; Jeremy Cohen; Dorrilyn Rajbhandari; Yaseen Arabi; Rinaldo Bellomo; Laurent Billot; Maryam Correa; Parisa Glass; Meg Harward; Christopher Joyce; Qiang Li; Colin McArthur; Anders Perner; Andrew Rhodes; Kelly Thompson; Steve Webb; John Myburgh
Journal:  N Engl J Med       Date:  2018-01-19       Impact factor: 91.245

8.  Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial.

Authors:  Djillali Annane; Alain Cariou; Virginie Maxime; Elie Azoulay; Gilles D'honneur; Jean François Timsit; Yves Cohen; Michel Wolf; Muriel Fartoukh; Christophe Adrie; Charles Santré; Pierre Edouard Bollaert; Armelle Mathonet; Roland Amathieu; Alexis Tabah; Christophe Clec'h; Julien Mayaux; Julie Lejeune; Sylvie Chevret
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

9.  The relationship between ICU hypotension and in-hospital mortality and morbidity in septic patients.

Authors:  Kamal Maheshwari; Brian H Nathanson; Sibyl H Munson; Victor Khangulov; Mitali Stevens; Hussain Badani; Ashish K Khanna; Daniel I Sessler
Journal:  Intensive Care Med       Date:  2018-06-05       Impact factor: 17.440

Review 10.  Vasoplegia treatments: the past, the present, and the future.

Authors:  Bruno Levy; Caroline Fritz; Elsa Tahon; Audrey Jacquot; Thomas Auchet; Antoine Kimmoun
Journal:  Crit Care       Date:  2018-02-27       Impact factor: 9.097
View more
  3 in total

1.  Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT.

Authors:  Paul R Mouncey; Alvin Richards-Belle; Karen Thomas; David A Harrison; M Zia Sadique; Richard D Grieve; Julie Camsooksai; Robert Darnell; Anthony C Gordon; Doreen Henry; Nicholas Hudson; Alexina J Mason; Michelle Saull; Chris Whitman; J Duncan Young; François Lamontagne; Kathryn M Rowan
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

Review 2.  Timing of vasoactive agents and corticosteroid initiation in septic shock.

Authors:  Mahmoud A Ammar; Abdalla A Ammar; Patrick M Wieruszewski; Brittany D Bissell; Micah T Long; Lauren Albert; Ashish K Khanna; Gretchen L Sacha
Journal:  Ann Intensive Care       Date:  2022-05-30       Impact factor: 10.318

Review 3.  Vasopressor Choice and Timing in Vasodilatory Shock.

Authors:  Patrick M Wieruszewski; Ashish K Khanna
Journal:  Crit Care       Date:  2022-03-22       Impact factor: 9.097
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.